Clinical Trials Directory

Trials / Completed

CompletedNCT04123938

Pea Protein and Muscle Mass During Weight Loss

A Pilot Study to Examine the Effect of Pea Protein on Limiting the Loss of Muscle Mass During Weight Loss

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
60 (actual)
Sponsor
University of Manitoba · Academic / Other
Sex
All
Age
30 Years – 50 Years
Healthy volunteers
Accepted

Summary

A pilot study comparing the effects of pea protein versus whey protein on the preservation of muscle mass and functionality in individuals undertaking a weight loss regimen.

Detailed description

A single site, double-blind, randomized clinical trial designed to compare the effects of pea protein or whey protein or maltodextrin supplementation on muscle mass and functionality in males and females with obesity undertaking a weight loss regimen. Eligible participants will be randomized to one of the three groups (pea protein, whey protein, maltodextrin) and will be asked to attend 3 in-person clinic visits (0, 6, and 12 weeks) for blood and urine collection and assessments of muscle mass and muscle function. A separate visit for screening and for a fasting blood sample, as well as a Pre-Study visit and a meeting with a registered dietitian, will be required.

Conditions

Interventions

TypeNameDescription
OTHERPea ProteinSoluble pea protein
OTHERWhey ProteinWhey protein concentrate
OTHERMaltodextrinNon-protein isocaloric comparator

Timeline

Start date
2019-10-17
Primary completion
2023-05-02
Completion
2023-05-02
First posted
2019-10-11
Last updated
2025-09-05

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT04123938. Inclusion in this directory is not an endorsement.